ALGS vs VMC · rev $3.6M vs P/E 35, rev $7.42B
Aligos Therapeutics Inc (ALGS) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
ALGS currently screens at market cap $44.1M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the ALGS and VMC stock pages for the full models.
Not investment advice.